J9172Docetaxel (docivyx), 1 mg

Published CMS Medicare Part B payment-limit context for J9172, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.

CMS payment limit

$46.287

per 1 MG · Medicare Part B

Down 8.5%from $50.607 in 2026-Q2

Current quarter: 2026-Q3FinalEffective July 1, 2026
Billing unit: 1 MG

Payment limit over time

$53.0404$45.4576

2024-Q4: Not published; 2025-Q1: $52.211; 2025-Q2: $51.62; 2025-Q3: $49.077; 2025-Q4: $50.778; 2026-Q1: $49.757; 2026-Q2: $50.607; 2026-Q3: $46.287

No current FDA shortage matchThe latest completed FDA data has no affected record matching the Docetaxel ingredient family (FDA data as of August 20, 2026).

Email me when FDA shortage status changes

Docivyx

Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.

Other Docetaxel presentations

3 other CMS codes

Source-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.

Swipe to see all columns

HCPCS	CMS description	Current quarter 2026-Q3	Prior quarter 2026-Q2	Change
J9171	Docetaxel injection	$0.456 per 1 MG	$0.556 per 1 MG	Down 18.0%
J9174	Inj, docetaxel (beizray) 1mg	$46.808 per 1 MG	Not published	Not available
J9232	Inj docetaxel (hospira) 1 mg	$0.512 per 1 MG	Not published	Not available

Put another code on your radar.

Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.

Explore CMS codes